Balance, Inc. (A)

Richard G. Hamermesh; Michele  Lutz

Case | HBS Case Collection | February 2001 (Revised May 2001)

Balance, Inc. (A)

by Richard G. Hamermesh and Michele Lutz

Abstract

Focuses on an entrepreneur who founded a successful health-food store and seeks to expand his retail concept. Illustrates the challenges he faces as he recruits his top management team.

Keywords: Distribution Channels; Executive Compensation; Agreements and Arrangements; Outcome or Result; Recruitment; Management Teams; Selection and Staffing; Food and Beverage Industry;

Format: Print

13 pages

Find at Harvard

Citation:

Hamermesh, Richard G., and Michele Lutz. "Balance, Inc. (A)." Harvard Business School Case 801-169, February 2001. (Revised May 2001.)

Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development engine. Blueprint’s drug development strategy was twofold—it focused on creating a single drug compound for multiple disease indications, while at the same time developing drugs to track a disease through its progression. The company’s goal was to become a fully integrated biopharmaceutical company that could move from drug discovery to development to marketing. But it was increasingly challenging to prioritize and manage programs, personnel and partnerships.

Faculty & Research

Balance, Inc. (A)

Abstract

Citation:

About the Author

More from the Author

Faculty & Research

Balance, Inc. (A)

Abstract

Citation:

Related Work

About the Author

More from the Author